Evolution 2.0 prize: The $10 million question

Major new prize announced to help identify how cells intentionally self-organise and communicate; George Church part of judging panel.

The origin of life is often cited as the greatest mystery on earth. But a new, and unprecedented, science prize is seeking the answer to what may be an even more fundamental question. Where exactly do cells get their information from? [1]

An incentive prize of $10 million, ten times that of the Nobel prize, is being offered to an individual or team who can provide the answers to how the genetic code inside cells got there, as well as how cells intentionally self-organise and communicate with each other before adapting. 

The investors and entrepreneurs seeking the answers say the prize could lead to a breakthrough as big as the discovery of DNA. [2]

Judges include Wyss Institute for Biologically Inspired Engineering core faculty member George Church, a Longevity opinion leader recently featured on this site for his research into making enhanced AAV capsids for targeted gene therapy

“Origin of life is the hardest question in science,” said Prof Church, adding: “It’s mind-boggling you can have such complex structures that make copies of themselves. But it’s very hard to do that with machines we’ve built. We are engineers but we’re rather poor ones compared to the pseudo engineering that is biological evolution.” 

Professor Church will be joined by fellow judges, including Oxford and Royal Society biologist Denis Noble, the first person in the world to model the human heart on computer, and philosopher of science Michael Ruse, to decide whether entrants really have answered the $10 million question. 

The Evolution 2.0 Prize has been designed and launched by business consultant Perry Marshall along with a team of genetic experts and investors from a wide range of sectors. It focuses on the big issues surrounding how cells reproduce, adapt and make choices on these key questions: How do you get from chemicals to code? How do you get a code without designing one? 

These are questions that could be increasingly important as Crispr techniques for gene-editing continue to improve. If we understand more, in the future, about genetic code and its origins, this could lead to major leaps in targeted gene editing to cure genetic conditions and disease. 

In order to win the prize, participants must create a digital communication system that can self evolve. 

The prize rules state, “If we can unearth the underlying forces that create and propel life, we stand to reap enormous benefits in Artificial Intelligence, engineering, computer science, nutrition, aging, health, cancer research, disease treatment and prevention.” 

Investor Gary Klopfenstein said: “If there is a winning entry, it will transform innovation for the next 50-100 years. This is not just an interesting initiative for a small sector of the scientific community but should be watched by the public in general.” Adding that this prize could provide a “front row seat to history.”

We will definitely be watching this space, and bringing you the latest updates on the Evolution 2.0 prize. If you think you could be the one making history, the prize rules are here

[1] https://bit.ly/37cy1Vg

[2] https://bit.ly/38o7O6b

Image credit: Arek Socha / Pixabay
Carla Heyworth
Carla is sub editor at Longevity.Technology and she's the glue that keeps the team on track and the articles rolling-out. She has an extensive background in B2B communications, events and marketing. Carla's a visual person and can often be found behind a camera or editing photos

Latest articles

Building an artificial immune system

DoD-funded ThirdLaw Technologies to harness the power of ‘spiroligomers’ to rapidly build new small molecules for Longevity therapies. Far from the world of stock market...

Neurotech is the new blue ocean

Alon Braun, Co-Founder, Neurotech Analytics.

Amazon and K4Connect demonstrate scalability for agetech

Covid-19 has been difficult for everyone, but particularly for people over the age of 65 who may spend months shut away from loved ones...

“Avoid the use of DQ as a senolytic therapy”

Forever Healthy Foundation issues risk-benefit analysis on dasatinib + quercetin as a senolytic. The Forever Healthy Foundation today published its latest risk-benefit analysis, which explores...